Tema ETFs LLC
Mutual FundPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2056807
New York, NY
Position in VRTX
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$4,304,645
-$53,051 QoQ
Shares Held
9,640
+0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tema ETFs LLC holds $99,221,898 across 48 Biotechnology names. VRTX ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
98,178 | $9,547,810 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
112,273 | $8,337,392 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
176,667 | $6,799,912 | |
| 4 | IMNM |
Immunome Inc.
|
275,896 | $6,033,845 | |
| 5 | NUVL |
Nuvalent, Inc.
|
53,415 | $5,472,366 | |
| 6 | CELC |
Celcuity Inc.
|
45,725 | $5,219,051 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
9,640 | $4,304,645 | |
| 8 | CGON |
CG Oncology, Inc.
|
63,163 | $4,274,871 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,304,645 | 9,640 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $4,357,696 | 9,612 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $3,779,717 | 9,651 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $3,591,873 | 8,068 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,095,759 | 8,448 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,422,048 | 10,981 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||